We are live on ! Find out more
ICU icon

SeaStar Medical

38 hedge funds and large institutions have $91.8M invested in SeaStar Medical in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

230% more capital inflows, than outflows

Capital inflows: $10.3M | Capital outflows: $3.11M

150% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 4

15% more funds holding

Funds holding: 33 → 38 (+5)

6.91% more ownership

Funds ownership: 70.21% → 77.12% (+6.9%)

Holders
38
Holders Change
+5
Holders Change %
+15.15%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
10
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ICU Hedge Fund Activity: Q3 2021 in Review

38 of the 5,733 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q3 2021, worth a combined $91.8M — up 26% from $72.7M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ICU positions and 2 closed out — a net gain of 5 holders — while 10 added to existing stakes and 4 trimmed.

The largest buyer was D.E. Shaw & Co, opening a new position worth an estimated $2.57M. The largest seller was Mangrove Partners, exiting entirely with an estimated $2.97M sold.

  • 38 institutional investors held SeaStar Medical (ICU) as of Q3 2021, up from 33 in Q2 2021.
  • Funds reported $91.8M of SeaStar Medical stock for Q3 2021, up 26% quarter-over-quarter.
  • 7 funds opened new SeaStar Medical positions in Q3 2021 and 2 closed out, a net change of +5 holders.
  • The largest SeaStar Medical buyer in Q3 2021 was D.E. Shaw & Co, an estimated $2.57M added.
  • The largest SeaStar Medical seller in Q3 2021 was Mangrove Partners, an estimated $2.97M sold.

Based on aggregated 13F filings for Q3 2021.